Sort
21,453 grants matching “tuberculosis”
Innovations in diagnosis for lymphadenopathy across HIV Centers of Excellence in Malawi
$544,250Matthew Scott Painschab · Univ Of North Carolina Chapel Hill · DP1 · FY2024 · CA
Innovations in diagnosis for lymphadenopathy across HIV Centers of Excellence in Malawi
$544,250Matthew Scott Painschab · Univ Of North Carolina Chapel Hill · DP1 · FY2025 · CA
DNA gyrase and quinolone resistance in tuberculosis
$544,245Public Health Research Institute · R01 · FY2004 · AI
Control of Bacterial Toxins by Viruses and Plasmids
$544,141Randall K Holmes · University Of Colorado Denver · R37 · FY2012 · AI
Control of Bacterial Toxins by Viruses and Plasmids
$544,141Randall K Holmes · University Of Colorado Denver · R37 · FY2014 · AI
Identification and Characterization of Genes Required for Listeria monocytogenes Cytosolic Survival
$544,104John-Demian Sauer · University Of Wisconsin-Madison · R01 · FY2021 · AI
Identification and Characterization of Genes Required for Listeria monocytogenes Cytosolic Survival
$544,104John-Demian Sauer · University Of Wisconsin-Madison · R01 · FY2019 · AI
Identification and Characterization of Genes Required for Listeria monocytogenes Cytosolic Survival
$544,104John-Demian Sauer · University Of Wisconsin-Madison · R01 · FY2022 · AI
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trial
$544,014Emily A Kendall · Johns Hopkins University · R01 · FY2022 · HL
Chemical Address Tags: A Cheminformatics & Image Data Management and Analysis Pla
$543,975Gus R Rosania · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$543,966Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2019 · AI
Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa
$543,856Max O'Donnell · Columbia University Health Sciences · R01 · FY2018 · AI
Metabolic adaptions of Mycobacterium tuberculosis at diverse host-pathogen interfaces
$543,819David Branch Moody · Brigham And Women'S Hospital · U19 · FY2022 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$543,651Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2022 · AI
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
$543,571Robert Owen Watson · Texas A&M University Health Science Ctr · R01 · FY2023 · AI
Emerging XDR-TB: Host and Pathogen Contributions
$543,505Dorothy A. Fallows · Rbhs-New Jersey Medical School · R01 · FY2013 · AI
Validation and Application of a Model for Human-like TB Latency in Rabbits
$543,503Veronique Dartois · Boston Medical Center · U19 · FY2016 · AI
Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa
$543,440Max O'Donnell · Columbia University Health Sciences · R01 · FY2017 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$543,390Mary Goggin · Colorado State Dept/Pub Hlth & Environmt · U52 · FY2011 · PS
The Function of Host-derived Extracellular Vesicles in Trafficking of Bacterial Antigens to Stimulate the Antibacterial Immune Response
$543,320Mariola Jadwiga Ferraro · University Of Florida · R01 · FY2022 · AI
RNA Vaccine Innovations for TB: Targeting the Mucosa
$543,301Steven G. Reed · Hdt Bio Corporation · R61 · FY2024 · AI
Investigating the basis of MAIT cell antigen potency
$543,227James McCluskey · University Of Melbourne · R01 · FY2020 · AI
Technology-Dev-Core
$543,199Sally M McFall · Northwestern University · U54 · FY2019 · EB
INTERCEPT
$543,195Reinout Van Crevel · Stichting Radboud Universitair Medisch Centrum I.O. · R01 · FY2024 · AI
Mechanism and inhibition of organic and enzymatic isomerizations
$543,183Andrew S Murkin · Suny At Buffalo · · FY2023 · MPS